98 related articles for article (PubMed ID: 24686178)
1. Mitogen-activated protein kinase phosphatase 1 negatively regulates MAPK signaling in mouse hypothalamus.
Adachi K; Goto M; Onoue T; Tsunekawa T; Shibata M; Hagimoto S; Ito Y; Banno R; Suga H; Sugimura Y; Oiso Y; Arima H
Neurosci Lett; 2014 May; 569():49-54. PubMed ID: 24686178
[TBL] [Abstract][Full Text] [Related]
2. MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells.
Manetsch M; Che W; Seidel P; Chen Y; Ammit AJ
Cell Signal; 2012 Apr; 24(4):907-13. PubMed ID: 22200679
[TBL] [Abstract][Full Text] [Related]
3. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
Srivastava N; Sudan R; Saha B
J Immunol; 2011 May; 186(10):5863-72. PubMed ID: 21471446
[TBL] [Abstract][Full Text] [Related]
4. MAPK phosphatase-1 (MKP-1) expression is up-regulated by hCG/cAMP and modulates steroidogenesis in MA-10 Leydig cells.
Brion L; Maloberti PM; Gomez NV; Poderoso C; Gorostizaga AB; Mori Sequeiros Garcia MM; Acquier AB; Cooke M; Mendez CF; Podesta EJ; Paz C
Endocrinology; 2011 Jul; 152(7):2665-77. PubMed ID: 21558315
[TBL] [Abstract][Full Text] [Related]
5. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
6. Regulation of tristetraprolin expression by mitogen-activated protein kinase phosphatase-1.
Huotari N; Hömmö T; Taimi V; Nieminen R; Moilanen E; Korhonen R
APMIS; 2012 Dec; 120(12):988-99. PubMed ID: 23030431
[TBL] [Abstract][Full Text] [Related]
7. Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit α and MAPK phosphatase-1 expression in human leukemia U937 cells.
Liu WH; Chen YJ; Cheng TL; Lin SR; Chang LS
Cell Signal; 2013 Sep; 25(9):1845-51. PubMed ID: 23707387
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance.
Wang Z; Xu J; Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 Sep; 66(17):8870-7. PubMed ID: 16951204
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1.
Jeong Y; Du R; Zhu X; Yin S; Wang J; Cui H; Cao W; Lowenstein CJ
J Leukoc Biol; 2014 Apr; 95(4):651-9. PubMed ID: 24374966
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer.
Boutros T; Chevet E; Metrakos P
Pharmacol Rev; 2008 Sep; 60(3):261-310. PubMed ID: 18922965
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells.
Turpeinen T; Nieminen R; Moilanen E; Korhonen R
J Pharmacol Exp Ther; 2010 Apr; 333(1):310-8. PubMed ID: 20089808
[TBL] [Abstract][Full Text] [Related]
13. ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
Wang J; Zhou JY; Wu GS
Cancer Res; 2007 Dec; 67(24):11933-41. PubMed ID: 18089824
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase phosphatase-1 expression in macrophages is controlled by lymphocytes during macrophage activation.
Luo C; Yang X; Yao L; Jiang L; Liu W; Li X; Wang L
Int J Mol Med; 2012 Jan; 29(1):25-31. PubMed ID: 21956667
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression.
Oride A; Kanasaki H; Purwana IN; Miyazaki K
Biochem Biophys Res Commun; 2009 May; 382(4):663-7. PubMed ID: 19289102
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
17. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ
J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375
[TBL] [Abstract][Full Text] [Related]
18. High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1.
Hashizume M; Mihara M
Biochem Biophys Res Commun; 2010 Dec; 403(2):184-9. PubMed ID: 21059338
[TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuates ethanol-induced toxicity in HT22 hippocampal cells by activating mitogen-activated protein kinase phosphatase-1.
Pae HO; Jeong SO; Zheng M; Ha HY; Lee KM; Kim EC; Kim DH; Hwang SY; Chung HT
Neurosci Lett; 2009 Apr; 453(3):186-9. PubMed ID: 19429032
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
